The JointJYNT -7.49%64 Days Payable is 42.74 as of Mar. 2026, which is 52% below its 10-year median of 88.87. GuruFocus rates JYNT with a GF Score™ of 64/100 and a GF Value™ of $11.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 608 Healthcare Providers & Services companies, The Joint ranks worse than 62.99% on this metric.
The Joint's average Accounts Payable for the
three
months ended in Mar. 2026 was $1.28 Mil. The Joint's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $2.72 Mil.
Hence, The Joint's Days Payable for the
three
months ended in Mar. 2026 was 42.74.
The historical rank and industry rank for The Joint's Days Payable or its related term are showing as below:
JYNT'
s Days Payable Range Over the Past 10 Years
Min: 42.3 Med: 88.87 Max: 189.45
Current: 42.3
During the past 13 years, The Joint's highest Days Payable was 189.45. The lowest was 42.30. And the median was 88.87.
JYNT's Days Payable is ranked worse than 62.99% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs JYNT: 42.30
The Joint's Days Payable
increased
from Mar. 2025 (42.56) to Mar. 2026 (42.74).
It may suggest that The Jointdelayed paying its suppliers.
The Joint Days Payable Related Terms
The Joint Days Payable Historical Data
* Premium members only.
The historical data trend for The Joint's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, The Joint's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Days Payable distribution charts can be found below:
* The bar in red indicates where The Joint's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
The Joint's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a Days Payable of 42.74 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on The Joint and its competitors. This is 52% below median its historical median of 88.87. Over the past decade, The Joint's Days Payable has ranged from 42.30 to 189.45. According to the industry distribution chart, The Joint ranks #383 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 63%.
Is The Joint's Days Payable too high?
The Joint's current Days Payable of 42.74 is 52% below median its 10-year median of 88.87. Over the past 10 years, this metric has ranged from a low of 42.30 to a high of 189.45. The Healthcare Providers & Services industry median Days Payable is 58.08. The Joint's value of 42.74 is 26.4% below this industry median. Based on the distribution chart, The Joint ranks #383 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, The Joint has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Days Payable compare to MAHN and WW?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #383 out of 608 companies for Days Payable. This places The Joint in the lower half of its industry. The industry median Days Payable is 58.08. The Joint's value of 42.74 is 26.4% below this benchmark. Historically, The Joint's own Days Payable has ranged from 42.30 to 189.45 over the past decade. While the company's 10-year median is 88.87 vs. the industry median of 58.08, The Joint has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current Days Payable of 42.74 is 26.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on The Joint and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current Days Payable is 42.74, which is 52% below median its own 10-year median of 88.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.11, compared to a current price of $8.52 — trading 23.3% below its estimated fair value. The current Days Payable is 42.74, which is 52% below median its 10-year median of 88.87 and 26.4% below the Healthcare Providers & Services industry median of 58.08. The Joint's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For The Joint (JYNT), the current Days Payable is 42.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.52 is trading 23.3% below its estimated GF Value™ of $11.11.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
Days Payable: 42.74 (52% below median its 10-year median of 88.87)
GF Value™: $11.11 vs. price of $8.52 (23.3% below fair value)
Industry Position: 26.4% below the Healthcare Providers & Services median (#383 of 608)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
64GF Score
Get the complete analysis for JYNT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
